Rockville, Maryland — January 8, 2026 — AAVnerGene Inc. (AAVnerGene) today announced the launch of AAVone®2.0, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system, delivering significant advances…
We are excited to announce that our scientist, Dr. Bing Wang, will be attending the Association for Research in Vision and Ophthalmology (ARVO), taking place May 4–8 in hashtag#SaltLakeCity, Utah.…
I’m thrilled to share the first results from our large-scale AAV production using the AAVone system in the XDR200 bioreactor. Utilizing the pAAVone-AAV9-CMV-EGFP plasmid, we achieved approximately 1e12 VG/L of…
The SAPA-CT 11th Annual Meeting took place at Yale University on December 7, 2024, under the theme “New Era of Innovation in Biomedicine.” The event was packed with insightful discussions…
📣 Create Your Ideal AAV Vectors Today and Accelerate Your #GeneTherapy Journey with us! 🚀 Ready to Get Started? There are 3 easy ways to design your AAV vector: 1️⃣Design…
Our President and CEO, Daozhan Yu, along with CTO Qizhao Wang, will represent AAVnerGene at the SAPA-CT 2024 Annual Conference this Saturday at Yale University! 🚀 Don’t miss Daozhan’s presentation,…
🎉AAVnerGene Inc. are excited to share that our CEO Daozhan Yu，CTO Qizhao Wang，and CBO Charles Li joined this momentous event—a Festschrift recognizing Dr. Jude Samulski’s exceptional contributions to genetherapy, AAV…
The current standard for manufacturing GMP-grade Adeo associated viral (AAV) vectors rely on a tri-plasmid system that involves transient transfection of mammalian cells with three plasmids carrying the necessary packaging…
📣Our CTO, Qizhao Wang, and CBO, Charles Li, are excited to join the Advanced Therapies USA 2024 in Philadelphia this weekend! We look forward to connecting with experts, sharing insights,…
Our President and CEO, Daozhan Yu, had the honor of moderating the CMC Panel at the Advancing Precision Mdicine Conference in Philadelphia. Panel Highlights:🔹 Industry Experts: Joined by leaders from…
Thank you all for coming by our booth at ESGCT2024 last week. We had a wonderful time connecting with experts and friends from around the world. Many were interested in…
At the 2024 Society for Neuroscience conference, AAVnerGene and Johns Hopkins University’s Division of Neurobiology presented an innovative poster that highlights the progress in developing gene therapies for Central Nervous System…
AAVnerGene was excited to participate in the 2024 Society for Neuroscience (SfN) conference, one of the premier events in the neuroscience community. We were thrilled to see an overwhelming response…
